VZ: Verizon Sourcing LLC 2022-07-19 08:30:00 Verizon awarded over $400M modernization contract with FBI
STIM: Neuronetics 2022-07-19 07:00:00 NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
DSX: Diana Shipping Inc. c/o Diana Shipping Services S.A. 2022-07-18 09:09:00 Diana Shipping Inc. Announces Time Charter Contract for m/v Boston with Aquavita
ETON: Eton Pharmaceuticals 2022-07-18 07:05:00 Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
DGLY: Digital Ally Inc. 2022-07-12 09:00:00 Digital Ally Awarded Notable Contract for Body-Worn Cameras
SCPH: scPharmaceuticals, Inc. 2022-07-12 08:00:00 scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure
RYTM: Rhythm Pharmaceuticals, Inc. 2022-07-12 07:00:00 Rhythm Pharmaceuticals Announces Positive Interim Results from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity
PESI: Perma-Fix Environmental Services, Inc 2022-07-11 08:30:00 Perma-Fix Among Three Suppliers Awarded Four-Year Framework Contract Worth up to £41 Million for the Treatment and Conditioning of Radioactive Waste in the UK
DLHC: DLH Holdings Corp. 2022-07-11 08:00:00 DLH Awarded NIH Cancer Epidemiology and Genetics Contract
MDWD: MediWound Ltd. 2022-07-11 07:00:00 MediWound Announces Positive Initial Data from its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
ICPT: Intercept Pharmaceuticals, Inc. 2022-07-07 07:30:00 Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)
MDWD: MediWound Ltd. 2022-07-07 07:00:00 MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers
DSX: Diana Shipping Inc. c/o Diana Shipping Services S.A. 2022-07-05 09:29:00 Diana Shipping Inc. Announces Time Charter Contracts for m/v Electra With Refind Success and m/v New York With C Transport.
RBCN: Rubicon Technology, Inc. 2022-07-05 08:00:00 Janel Corporation to Launch a Cash Tender Offer to Acquire a 45% Interest in Rubicon Technology, Inc at $20 per Share.
CARA: Cara Therapeutics, Inc. 2022-06-30 07:00:00 Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Nostalgia Paresthetica
TZOO: Travelzoo 2022-06-23 08:55:23 Travelzoo Announces Share Repurchase Program
RDUS: Radius Health Inc. 2022-06-23 09:15:00 Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital
ZYNE: Zynerba Pharmaceuticals, Inc. 2022-06-22 20:05:00 Zynerba Pharmaceuticals Announces Positive Top Line Results from Open-Label Phase 2 INSPIRE Trial of Zygel™ in 22q11.2 Deletion Syndrome